CD274 and neoplasm: A recent study suggested that TDEs carrying programmed cell death 1 ligand 1 (PD-L1) retain immunosuppressive activity by downregulating T-cell surface CD69.142 Recent research has shown that EVs produced by tumor cells also exhibit significant PD-L1 (Programmed Death Ligand) expression levels.